"Hematological cancer" trang 1 - tải miễn phí từ tailieunhanh
Distribution and features of hematological malignancies in Eastern Morocco: A retrospective multicenter study over 5 years

Distribution and features of hematological malignancies in Eastern Morocco: A retrospective multicenter study over 5 years
10    58    1
Trauma- and stressor-related disorders among hematological cancer patients with and without stem cell transplantation: Protocol of an interview-based study according to updated diagnostic criteria

Trauma- and stressor-related disorders among hematological cancer patients with and without stem cell transplantation: Protocol of an interview-based study according to updated diagnostic criteria
9    88    0
Assessment of the results and hematological side effects of 3D conformal and IMRT/ARC therapies delivered during craniospinal irradiation of childhood tumors with a follow-up period of five years

Assessment of the results and hematological side effects of 3D conformal and IMRT/ARC therapies delivered during craniospinal irradiation of childhood tumors with a follow-up period of five years
7    82    1
Diagnosed hematological malignancies in Bangladesh - a retrospective analysis of over 5000 cases from 10 specialized hospitals

Diagnosed hematological malignancies in Bangladesh - a retrospective analysis of over 5000 cases from 10 specialized hospitals
7    36    1
Pharmacokinetics of piperacillin/tazobactam in cancer patients with hematological malignancies and febrile neutropenia after chemotherapy

Pharmacokinetics of piperacillin/tazobactam in cancer patients with hematological malignancies and febrile neutropenia after chemotherapy
6    72    0
Prevalence and associated factors of medication non-adherence in hematological-oncological patients in their home situation

Prevalence and associated factors of medication non-adherence in hematological-oncological patients in their home situation
8    67    1
Long-term effects and psychological adjustment: Study protocol of a large register-based study on quality of life among survivors of hematological malignancies

Long-term effects and psychological adjustment: Study protocol of a large register-based study on quality of life among survivors of hematological malignancies
10    57    1
A comprehensive study of risk factors for post-operative pneumonia following resection of meningioma

A comprehensive study of risk factors for post-operative pneumonia following resection of meningioma
9    53    1
Network meta-analysis of triazole, polyene, and echinocandin antifungal agents in invasive fungal infection prophylaxis in patients with hematological malignancies

Network meta-analysis of triazole, polyene, and echinocandin antifungal agents in invasive fungal infection prophylaxis in patients with hematological malignancies
17    32    1
Prognostic value of preoperative hematological markers in patients with glioblastoma multiforme and construction of random survival forest model

Prognostic value of preoperative hematological markers in patients with glioblastoma multiforme and construction of random survival forest model
13    5    1
Cytokine release syndrome was an independent risk factor associated with hypoalbuminemia for patients with relapsed/refractory hematological malignancies after CAR-T cell therapy

Cytokine release syndrome was an independent risk factor associated with hypoalbuminemia for patients with relapsed/refractory hematological malignancies after CAR-T cell therapy
8    8    1
An observational study of dose dense chemotherapy with lipegfilgrastim support in early breast cancer

An observational study of dose dense chemotherapy with lipegfilgrastim support in early breast cancer
7    4    1
Chemotherapy induced neutropenia at 1-month mark is a predictor of overall survival in patients receiving TAS-102 for refractory metastatic colorectal cancer: A cohort study

Chemotherapy induced neutropenia at 1-month mark is a predictor of overall survival in patients receiving TAS-102 for refractory metastatic colorectal cancer: A cohort study
7    68    1
CYP39A1 polymorphism is associated with toxicity during intensive induction chemotherapy in patients with advanced head and neck cancer

CYP39A1 polymorphism is associated with toxicity during intensive induction chemotherapy in patients with advanced head and neck cancer
7    78    1
The impact of comorbid disease history on all-cause and cancer-specific mortality in myeloid leukemia and myeloma – a Swedish population-based study

The impact of comorbid disease history on all-cause and cancer-specific mortality in myeloid leukemia and myeloma – a Swedish population-based study
12    33    1
Evaluation of body-surface-area adjusted dosing of high-dose methotrexate by population pharmacokinetics in a large cohort of cancer patients

Evaluation of body-surface-area adjusted dosing of high-dose methotrexate by population pharmacokinetics in a large cohort of cancer patients
10    40    1
Age as a potential predictor of acute side effects during chemoradiotherapy in primary cervical cancer patients

Age as a potential predictor of acute side effects during chemoradiotherapy in primary cervical cancer patients
10    26    1
Clinical value of circulating tumor cells and hematological parameters in 617 Chinese patients with colorectal cancer: retrospective analysis

Clinical value of circulating tumor cells and hematological parameters in 617 Chinese patients with colorectal cancer: retrospective analysis
7    1    1
Safety and efficacy of pegylated recombinant human granulocyte colony-stimulating factor during concurrent chemoradiotherapy for small-cell lung cancer: A retrospective, cohort-controlled trial

Safety and efficacy of pegylated recombinant human granulocyte colony-stimulating factor during concurrent chemoradiotherapy for small-cell lung cancer: A retrospective, cohort-controlled trial
10    17    1
Feasibility of whole body vibration during intensive chemotherapy in patients with hematological malignancies – a randomized controlled pilot study

Feasibility of whole body vibration during intensive chemotherapy in patients with hematological malignancies – a randomized controlled pilot study
12    58    1